Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC
Proceeds support continued development and commercialization of cell engineering platform technology across research and clinical applications. Over 20 active partners…
Pharmaceuticals, Biotechnology and Life Sciences
Proceeds support continued development and commercialization of cell engineering platform technology across research and clinical applications. Over 20 active partners…
DUBLIN–(BUSINESS WIRE)–The “USA Patient Registry Software Market Outlook to 2028” report has been added to ResearchAndMarkets.com’s offering. The United States…
SAN DIEGO–(BUSINESS WIRE)–Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, solidifies its stature as a…
ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the…
MELBOURNE, Australia and DRESDEN, Germany, March 19, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today…
– Awards Dr. Berkowitz an Inducement Grant in accordance with Nasdaq Listing Rule 5635(c)(4) -NEW HAVEN, Conn., March 18, 2024…
BEDFORD, Mass., March 18, 2024 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX) today announced that it declared a distribution…
SAN DIEGO and TORONTO, March 18, 2024 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical- stage…
– Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in…
– Preliminary LUNA data presented at the Annual Meeting of the Macula Society support potential best-in-class clinical activity and an…